Squarepoint
TPTX

Squarepoint’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Squarepoint’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-8,797
Closed -$662K – 3644
2022
Q2 		$662K Sell
8,797
-45,050
-84% -$2M ﹤0.01% 1854
2022
Q1 		$1.45M Buy
+53,847
New +$1.81M 0.01% 1361
2021
Q4 		– Sell
-3,155
Closed -$210K – 3668
2021
Q3 		$210K Buy
+3,155
New +$225K ﹤0.01% 2462
2021
Q2 		– Sell
-6,190
Closed -$586K – 3930
2021
Q1 		$586K Buy
6,190
+4,480
+262% +$533K ﹤0.01% 1901
2020
Q4 		$208K Sell
1,710
-3,195
-65% -$350K ﹤0.01% 2480
2020
Q3 		$429K Buy
+4,905
New +$342K 0.01% 1542
2020
Q2 		– Sell
-6,370
Closed -$284K – 2622
2020
Q1 		$284K Sell
6,370
-10,450
-62% -$555K 0.01% 1322
2019
Q4 		$1.05M Buy
16,820
+3,708
+28% +$176K 0.01% 1300
2019
Q3 		$493K Buy
+13,112
New +$571K ﹤0.01% 1624

Squarepoint's TPTX Position: Q3 2022 in Review

Squarepoint sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 8,797 shares — an estimated $662K sold.

Squarepoint first reported a position in TPTX in Q3 2019 and held it in 9 quarters. The position peaked at $1.45M in Q1 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Squarepoint reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Squarepoint sold 8,797 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $662K.
  • Squarepoint first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 9 quarters.
  • Squarepoint's Turning Point Therapeutics, Inc. Common Stock position peaked at $1.45M in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Squarepoint's 13F filing for Q3 2022, filed 14 Nov 2022.